Dynamic Cellular Interactions Associated with Inflammatory Monocyte Accumulation in the Neurovasculature with Social Stress
与社交压力下神经血管系统中炎症性单核细胞积聚相关的动态细胞相互作用
基本信息
- 批准号:10551334
- 负责人:
- 金额:$ 51.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnxietyBehavioralBone MarrowBrainBrain regionCCL2 geneCSF1R geneCellsChemosensitizationCirculationDataDevelopmentDextransEndothelial CellsEndotheliumEnzymesEventFemaleFingerprintGene Expression ProfilingGenetic TranscriptionGoalsHealthHumanIL1R1 geneImmunologicsInflammationInflammatoryInterleukin-1 ReceptorsInterleukin-1 betaInterventionKnowledgeLigandsMediatingMental DepressionMental HealthMessenger RNAMicrogliaMusNeuronsPTGS2 genePrevalencePrincipal InvestigatorProductionProstaglandinsPsychological StressPsychosocial StressPurinoceptorQuality of lifeRecruitment ActivityReporterReportingRoleSignal TransductionSpecificityStressTestingTherapeutic InterventionWorkantagonistanxiety-like behaviorchemokinecytokineglial activationmRNA Expressionmalemonocytemouse modelneuroinflammationneuropsychiatryneurovascularnew therapeutic targetnovelpre-clinicalpreventprogramsrecruitresponsesocial defeatsocial stress
项目摘要
Program Director/Principal Investigator (Sheridan, JF & Godbout JP):
PROJECT SUMMARY/ABSTRACT:
Dynamic inflammatory signaling in the brain may have a causative role in anxiety. We report that repeated
social defeat (RSD) in mice induces sympathetic-mediated release of primed monocytes from the bone marrow
that are actively recruited to the brain. Collectively, we show that RSD promotes prolonged anxiety-like
behavior that depends on activation of microglia and recruitment of inflammatory monocytes to threat appraisal
regions of the brain. This application demonstrates that microglial recruitment of IL-1β producing monocytes to
neurovascular endothelium is necessary for the potentiation of anxiety-like behavior in response to social
stress. Despite this knowledge, three key mechanistic questions remain to be answered, which will allow for
the development of novel interventions for treatment of neuropsychiatric complications associated with stress:
1) How does RSD activate microglia in threat appraisal regions? 2) How are inflammatory monocytes
selectivity recruited to neurovascular endothelium in threat appraisal regions? 3) What are the key factors
produced by neurovascular endothelia cells that potentiate neuroinflammation and anxiety? We show that
microglial activation in response to RSD depends on neuronal activation within threat appraisal regions.
Moreover, preliminary evidence suggests that this is mediated by activation of the purinergic receptor, P2RX7,
on microglia. Novel data presented here show that monocyte recruitment and the development of anxiety-like
behavior after RSD requires microglial activation. Furthermore, cell-specific transcriptional profiling indicates
that microglia recruit monocytes to the brain via chemokine ligand (CCL2) secretion. These recruited
monocytes produce IL-1and promote anxiety-like behavior by endothelial IL-1 Receptor-1 activation. Notably,
this IL-1R1 activation is associated with increased neurovascular expression of COX2, the enzyme that
synthesizes neuroactive prostaglandins. Thus, the goal of this project is to test the hypothesis that recruitment
and subsequent interaction of inflammatory monocytes with neurovascular endothelial cells is critical for the
augmentation of neuroinflammation and potentiation of anxiety-like behavior following RSD. To address this
hypothesis, three specific aims are proposed. In Aim-1, we will ascertain the extent to which RSD-induced
microglial activation is dependent on stimulation of the P2RX7 purinergic receptor. In Aim-2, we will determine
the degree to which microglial production of CCL2 is required for monocyte recruitment to threat appraisal
regions and the induction of anxiety-like behavior after RSD. In Aim-3, we will assess the role of endothelial
COX2 following RSD and determine other key factors produced by IL-1R1-stimulated endothelial cells that
facilitate anxiety-like behavior after RSD. Understanding how microglial recruitment of IL-1β producing
monocytes to threat appraisal regions potentiates neuroinflammation and anxiety-like behavior will lead to new
interventions for neuropsychiatric complications associated with stress.
PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
项目总监/首席调查员(Sheridan,JF&Godout JP):
项目摘要/摘要:
大脑中的动态炎症信号可能是导致焦虑的原因之一。我们反复报告说
小鼠社会挫败(RSD)诱导交感神经介导的骨髓单核细胞释放
它们被积极地招募到大脑中。总而言之,我们表明,RSD促进了长期的焦虑
依赖于小胶质细胞的激活和炎性单核细胞的招募来评估威胁的行为
大脑的不同区域。这一应用表明,小胶质细胞募集产生IL-1β的单核细胞
神经血管内皮细胞对社会反应中焦虑样行为的增强是必需的
压力。尽管有这些知识,但仍有三个关键的机械问题有待回答,这将使
治疗与应激相关的神经精神并发症的新干预措施的开发:
1)RSD如何激活威胁评估区域的小胶质细胞?2)炎性单核细胞如何
威胁评估区域对神经血管内皮细胞的选择性招募?3)关键因素是什么
由神经血管内皮细胞产生,会加剧神经炎症和焦虑吗?我们证明了
小胶质细胞对RSD的反应依赖于威胁评估区域内神经元的激活。
此外,初步证据表明,这是通过激活嘌呤能受体P2RX7来调节的,
在小胶质细胞上。这里提供的新数据表明,单核细胞招募和焦虑症样的发展
RSD后的行为需要小胶质细胞的激活。此外,细胞特异性转录图谱表明
小胶质细胞通过分泌趋化因子配体(CCL2)将单核细胞招募到脑内。这些人招募了
单核细胞产生IL-1,并通过内皮细胞IL-1受体-1激活促进焦虑样行为。值得注意的是,
这种IL-1R1的激活与COX2神经血管表达的增加有关,COX2是一种能够
合成神经活性前列腺素。因此,这个项目的目标是检验招聘的假设
随后炎性单核细胞与神经血管内皮细胞的相互作用对
RSD后神经炎症加重和焦虑样行为增强。要解决这个问题
假设,提出了三个具体目标。在AIM-1中,我们将确定区域可持续发展导致的
小胶质细胞的激活依赖于P2RX7嘌呤能受体的刺激。在AIM-2中,我们将确定
单核细胞募集到威胁评估所需的小胶质细胞产生CCL2的程度
区域与RSD后焦虑样行为的诱导。在AIM-3中,我们将评估内皮细胞的作用
COX2跟随RSD,并确定IL-1R1刺激的内皮细胞产生的其他关键因子
促进RSD后焦虑样行为。了解小胶质细胞募集如何产生IL-1β
单核细胞到威胁评估区域加重神经炎症和焦虑样行为将导致新的
与应激相关的神经精神并发症的干预。
PHS 398/2590(06/09版)页面续格式页面
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan P Godbout其他文献
Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal
反复的社会挫败、神经炎症与行为:单核细胞传递信号
- DOI:
10.1038/npp.2016.102 - 发表时间:
2016-06-20 - 期刊:
- 影响因子:7.100
- 作者:
Michael D Weber;Jonathan P Godbout;John F Sheridan - 通讯作者:
John F Sheridan
Microglia Priming with Aging and Stress
衰老和应激对小胶质细胞的启动
- DOI:
10.1038/npp.2016.185 - 发表时间:
2016-09-08 - 期刊:
- 影响因子:7.100
- 作者:
Anzela Niraula;John F Sheridan;Jonathan P Godbout - 通讯作者:
Jonathan P Godbout
Jonathan P Godbout的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan P Godbout', 18)}}的其他基金
Chronic and Evolving Inflammation after Traumatic Brain Injury: Microglial Priming and Neuropsychiatric Complications
脑外伤后慢性和演变的炎症:小胶质细胞启动和神经精神并发症
- 批准号:
10374923 - 财政年份:2021
- 资助金额:
$ 51.56万 - 项目类别:
Chronic and Evolving Inflammation after Traumatic Brain Injury: Microglial Priming and Neuropsychiatric Complications
脑外伤后慢性和演变的炎症:小胶质细胞启动和神经精神并发症
- 批准号:
10218388 - 财政年份:2021
- 资助金额:
$ 51.56万 - 项目类别:
Chronic and Evolving Inflammation after Traumatic Brain Injury: Microglial Priming and Neuropsychiatric Complications
脑外伤后慢性和演变的炎症:小胶质细胞启动和神经精神并发症
- 批准号:
10599313 - 财政年份:2021
- 资助金额:
$ 51.56万 - 项目类别:
Dynamic Cellular Interactions Associated with Inflammatory Monocyte Accumulation in the Neurovasculature with Social Stress
与社交压力下神经血管系统中炎症性单核细胞积聚相关的动态细胞相互作用
- 批准号:
10348144 - 财政年份:2019
- 资助金额:
$ 51.56万 - 项目类别:
Dynamic Cellular Interactions Associated with Inflammatory Monocyte Accumulation in the Neurovasculature with Social Stress
与社交压力下神经血管系统中炎症性单核细胞积聚相关的动态细胞相互作用
- 批准号:
10087968 - 财政年份:2019
- 资助金额:
$ 51.56万 - 项目类别:
Acute and Long-Term Benefits of Methylene blue Intervention after TBI on Neuroinflammation, Glial Dysfunction, and Neuropsychiatric Complications
TBI 后亚甲蓝干预对神经炎症、神经胶质功能障碍和神经精神并发症的短期和长期益处
- 批准号:
9512139 - 财政年份:2017
- 资助金额:
$ 51.56万 - 项目类别:
相似海外基金
A Randomized Controlled Trial of Cognitive Behavioral Therapy via Videoconference for Anxiety in Children and Adolescents
通过视频会议进行认知行为疗法治疗儿童和青少年焦虑的随机对照试验
- 批准号:
23K02949 - 财政年份:2023
- 资助金额:
$ 51.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Behavioral telehealth in low-resource primary care settings for anxiety and depression in youth: A randomized effectiveness-implementation study
资源匮乏的初级保健机构中针对青少年焦虑和抑郁的行为远程医疗:一项随机有效性实施研究
- 批准号:
10731716 - 财政年份:2023
- 资助金额:
$ 51.56万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 51.56万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Adaptation and implementation of a behavioral mHealth intervention to reduce anxiety and depression and end the HIV epidemic in the rural South
适应和实施行为移动健康干预措施,以减少焦虑和抑郁并结束南方农村地区的艾滋病毒流行
- 批准号:
10619925 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
Development of an Individualized Cognitive Behavioral Therapy Program for Depression and Anxiety in Older Adults
开发针对老年人抑郁和焦虑的个体化认知行为治疗方案
- 批准号:
22K03175 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10355810 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
Feasibility, Preliminary Effectiveness, and Sustainability of a Cognitive-Behavioral Therapy Program Tailored for Youth with Autism and Anxiety Treated in Real-World Community-Based Clinics
为患有自闭症和焦虑症的青少年量身定制的认知行为治疗计划的可行性、初步有效性和可持续性,并在现实世界的社区诊所进行治疗
- 批准号:
10542409 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
An Empirical Study of Cognitive Behavioral Therapy Approaching Anxiety and Related Autism Spectrum Disorder Traits
认知行为疗法治疗焦虑及相关自闭症谱系障碍特征的实证研究
- 批准号:
22H01089 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Feasibility, Preliminary Effectiveness, and Sustainability of a Cognitive-Behavioral Therapy Program Tailored for Youth with Autism and Anxiety Treated in Real-World Community-Based Clinics
为患有自闭症和焦虑症的青少年量身定制的认知行为治疗计划的可行性、初步有效性和可持续性,并在现实世界的社区诊所进行治疗
- 批准号:
10355838 - 财政年份:2022
- 资助金额:
$ 51.56万 - 项目类别: